Entry |
|
Name |
Mutation-inactivated AXIN to Wnt signaling pathway
|
Definition |
(GSK3B+APC) // AXIN* // CTNNB1 -> TCF/LEF => (MYC,CCND1) |
Expanded |
(2932+324) // 8312v1 // 1499 -> (6932,83439,6934,51176) => (4609,595) |
Class |
|
Type |
Variant
|
Pathway |
|
Disease |
H00048 | Hepatocellular carcinoma |
|
Gene |
2932 | GSK3B; glycogen synthase kinase 3 beta |
324 | APC; APC, WNT signaling pathway regulator |
1499 | CTNNB1; catenin beta 1 |
6932 | TCF7; transcription factor 7 |
83439 | TCF7L1; transcription factor 7 like 1 |
6934 | TCF7L2; transcription factor 7 like 2 |
51176 | LEF1; lymphoid enhancer binding factor 1 |
4609 | MYC; MYC proto-oncogene, bHLH transcription factor |
|
Variant |
|
Reference |
|
Authors |
Polakis P |
Title |
Wnt signaling in cancer. |
Journal |
|
Reference |
|
Authors |
Salahshor S, Woodgett JR |
Title |
The links between axin and carcinogenesis. |
Journal |
|
Reference |
|
Authors |
Taniguchi K, Roberts LR, Aderca IN, Dong X, Qian C, Murphy LM, Nagorney DM, Burgart LJ, Roche PC, Smith DI, Ross JA, Liu W |
Title |
Mutational spectrum of beta-catenin, AXIN1, and AXIN2 in hepatocellular carcinomas and hepatoblastomas. |
Journal |
|
Reference |
|
Authors |
Mazzoni SM, Fearon ER |
Title |
AXIN1 and AXIN2 variants in gastrointestinal cancers. |
Journal |
|
Reference |
|
Authors |
Kumar M, Zhao X, Wang XW |
Title |
Molecular carcinogenesis of hepatocellular carcinoma and intrahepatic cholangiocarcinoma: one step closer to personalized medicine? |
Journal |
|
Reference |
|
Authors |
Villanueva A, Newell P, Chiang DY, Friedman SL, Llovet JM. |
Title |
Genomics and signaling pathways in hepatocellular carcinoma. |
Journal |
|
LinkDB |
|